Pituitary Adenoma Clinical Trial
Official title:
Prospective Multicenter Cohort Study Comparing Extent of Tumor Resection Between Microscopic Transsphenoidal Surgery and Fully Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas
The purpose of this research study is to compare the extent of resection (EOR) in patients with nonfunctioning pituitary adenomas undergoing transsphenoidal surgery using a microsurgical technique to those patients who have undergone surgery with a fully endoscopic technique. Another goal is to compare surgical complications, endocrine outcomes, visual outcomes, length of surgery, length of hospital stay, and readmission rates between the two transsphenoidal surgery techniques. This is an observational data collection study with no experimental procedures or experimental medicines. Endonasal transsphenoidal removal of a pituitary tumor is a unique procedure and there is little information comparing the two surgical techniques.
The treatment of choice for most patients with symptomatic nonfunctioning pituitary adenomas
is transsphenoidal surgery to improve vision by decompression of the optic chiasm, to prevent
the development of endocrine dysfunction, and to treat neurological symptoms such as headache
or cranial neuropathies caused by the tumor. The most widely accepted surgical technique is
microscopic transsphenoidal surgery, in which an operating microscope is used by the surgeon
to provide surgical visualization and a nasal speculum is used to maintain the operative
corridor. [1-4] Recently, fully endoscopic transsphenoidal surgery, in which surgical
visualization is achieved using an endoscope, has been adopted by many pituitary surgeons
because the technique offers superior panoramic and angled visualization of the surgical
target and may permit greater tumor resection. [5-10] There is a vigorous debate in the
neurosurgical community about the relative merits of the microscopic and endoscopic
techniques. Proponents of the endoscopic technique argue that the superior visualization
permits more aggressive tumor resection and better preservation of the normal pituitary
gland. Proponents of the microscopic technique argue that it permits shorter operative times,
results in similar surgical outcomes, and has a lower complication rate.
Despite the adoption of fully endoscopic surgery by many surgeons, no prospective studies
have compared the extent of tumor resection (EOR) between microscopic and endoscopic
approaches. Numerous retrospective studies have established the efficacy of each approach,
but only a few studies present comparative data.[11-13] Recently, McLaughlin et al. noted
that the addition of endoscopy to microscopic pituitary surgery enhances tumor removal,
particularly in patients with tumors greater than 20 mm in diameter. [14] This study raises
the intriguing possibility that certain subgroups of patients (e.g. patients with larger
tumors) may benefit from endoscopic surgery. In patients with smaller tumors with no
cavernous sinus invasion, others have shown that the techniques achieve similar EOR. [15]
That endoscopy may permit more complete tumor resections is a testable hypothesis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04081701 -
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
|
Phase 4 | |
Completed |
NCT01689064 -
Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection
|
N/A | |
Recruiting |
NCT04611685 -
Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas
|
N/A | |
Completed |
NCT04212793 -
Detection of PitNET Tissue During TSS Using Bevacizumab-800CW
|
Phase 1 | |
Recruiting |
NCT02709863 -
Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests
|
N/A | |
Completed |
NCT01465672 -
Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
|
N/A | |
Terminated |
NCT00798057 -
Proton Radiation Therapy for Pituitary Adenoma
|
N/A | |
Completed |
NCT01504399 -
Rhinological Outcomes in Endonasal Pituitary Surgery
|
||
Recruiting |
NCT01556230 -
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
|
||
Completed |
NCT04074642 -
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
|
N/A | |
Recruiting |
NCT04621565 -
Hydrocortisone Use During Peri-operation for Pituitary Adenomas
|
N/A | |
Completed |
NCT04076046 -
Multicentric Prospective Validation of the Zurich Pituitary Score
|
||
Not yet recruiting |
NCT03714763 -
Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)
|
N/A | |
Recruiting |
NCT05822817 -
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
|
Phase 4 | |
Recruiting |
NCT03164148 -
Heart Rate Variability (HRV) in Pituitary Adenoma
|
N/A | |
Completed |
NCT04284605 -
Effects Exercise Training in Patients With Pituitary Adenoma
|
N/A | |
Terminated |
NCT03515603 -
Endocrine Outcome of Surgery for Pituitary Adenoma
|
N/A | |
Not yet recruiting |
NCT04863456 -
Efficiency and Safety of Different Treatment Strategies in Adults With Pituitary Adenomas With Hypothalamic Involvement
|
N/A | |
Active, not recruiting |
NCT03465618 -
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
|
Phase 1 | |
Completed |
NCT02727686 -
Post-Operative Water Load Following Transsphenoidal Pituitary Surgery
|
N/A |